BioNxt Solutions Inc. BioNxt Solutions Inc.

BioNxt Solutions Inc.

BNXT

Rank in Stocks #25306
Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017,... Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017, operates as a bioscience company across Germany, Switzerland, Austria, Israel, and its home country. The firm focuses on developing innovative drug delivery systems, including transdermal patches and oral dissolvable films, specifically for neurological medications. It also advances psychedelic medicine applications to treat various mental health conditions such as depression, anxiety, addiction, and trauma-related stress disorder. Furthermore, BioNxt is engaged in creating point-of-care diagnostics, comprising rapid tests and biosensor screening tools, aimed at early disease detection, improved treatment efficacy, and enhanced disease management. This diagnostic portfolio features a COVID-19 PCR kit, alongside oral biosensors for peri-implantitis, H1N1 (swine flu), and H5N1 (avian flu). Complementing its development efforts, the company provides analytical testing and consulting services, and is involved in pathogen and oral health diagnostics, thin film drug formulation, and the production and formulation of psychedelic pharmaceuticals. The company adopted its current name in November 2022, having previously been known as XPhyto Therapeutics Corp.
Share Price
$0.20182135
Last synced: 2026-11-10
Market Cap
$26.23M
Change (1 day)
9.62%
Change (1 year)
-60.60%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for BioNxt Solutions Inc. (BNXT)
EPS as of June 2026 TTM: $-0.05
According to BioNxt Solutions Inc.'s latest financial reports, its current EPS (TTM) is $-0.05. At the end of 2025 the company had an EPS of $-0.04, a decrease compared to its 2024 EPS of $-0.03.
EPS history for BioNxt Solutions Inc. from 2017 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.05 29.50%
2025 $-0.04 30.42%
2024 $-0.03 -45.03%
2023 $-0.06 -45.34%
2022 $-0.11 -51.83%
2021 $-0.23 -2.67%
2020 $-0.24 104.42%
2019 $-0.12 786.92%
2018 $-0.01 12,900.00%
2017 0.00 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$6.03 -11,740.73%
DE
$6.01 -11,698.07%
DE
$1.53 -3,059.27%
JP
$3.66 -7,165.64%
CH
$0.45 -968.73%
IL

Questions about BioNxt Solutions Inc.'s earnings per share (EPS)

What is BioNxt Solutions Inc.'s earnings per share (EPS)?

BioNxt Solutions Inc.'s earnings per share (EPS) over the last twelve months is $-0.05, as of Jun 2026.

What was BioNxt Solutions Inc.'s earnings per share (EPS) in 2025?

In 2025, BioNxt Solutions Inc.'s earnings per share (EPS) was $-0.04, compared with $-0.03 in 2024.

How has BioNxt Solutions Inc.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, BioNxt Solutions Inc.'s earnings per share (EPS) was highest in 2024 ($-0.03) and lowest in 2020 ($-0.24).

How does BioNxt Solutions Inc.'s earnings per share (EPS) compare with similar companies?

BioNxt Solutions Inc.'s earnings per share (EPS) ($-0.05) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.